CBD Could Become A Dietary Supplement!
We recently covered the good news regarding the USDA ruling on what Hemp Farmers should do with "Hot" Hemp. Today, we're talking about even more good news regarding Hemp!
On September 3rd, 2020, Bill H.R.-8179 was put forth to congress that is one of the most CBD friendly acts by congress ever. Titled The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020, this is a bi-partisian bill, put forth by Rep. Kurt Schrader (D-OR) & Rep. Morgan Griffth (R-VA).
If passed, this landmark bill would make CBD fall under the category of dietary supplements, and thus held to the same regulations that are required of dietary supplements.
According to the U.S. Hemp Roundtable, “This bill would require CBD and Hemp extract product manufacturers to comply with the entire existing comprehensive regulatory framework for dietary supplements, which ensures that the products are deemed safe, properly labeled, and prepared utilizing Good Manufacturing Practices.”
Should this bill pass & become law, CBD becoming a dietary supplement would be a game changer for our industry. First, companies that are already certified by the U.S. Hemp Authority should be in good standing with any new regulations placed on the industry.
Secondly, this bill would help eliminate the bad actors in CBD that market their products improperly, mislabel them, or flat out sell unlawful products.
Thirdly, this law would bring more consumer confidence to hemp-derived products, therefore allowing larger big box retailers to carry these products, increasing demand, and really make the hemp market a dominant force in the U.S. economy.
Why CBD Isn’t Already A Dietary Supplement
The fight to get CBD labeled as a dietary supplement has long been an issue for all stakeholders in the Hemp industry.
This issue originated because of the Dietary Supplement Health and Education Act of 1994. This law states that a product that contains ingredients from an FDA approved medication cannot be sold as a dietary supplement.
This is where Epidolex comes into play, as it is an FDA prescribed CBD solution that can help children that suffer from seizures. This drug was approved in 2018, but before it was approved, the FDA still claimed that CBD couldn’t be marketed as a dietary supplement because Epidolex was being researched.
There is an exception to this rule, which states if a product has been marketed/sold before the FDA decides to research it’s possible therapeutic benefits, then you can still sell the product as a dietary supplement.
There isn’t much research to back that CBD alone was sold this way before the trials for Epidolex began, but, Cannabis/Hemp has been around long before the FDA, so one could argue it’s been sold as a “dietary supplement” for thousands of years.
Another argument for why CBD should already be considered a dietary supplement is that many hemp-derived products on the market today are actually different from the CBD that’s contained in Epidiolex. Epidolex uses a CBD isolate, while most companies selling CBD today offer either a Full or Broad Spectrum product. These terms mean that there isn’t just CBD in the ingredients, but other Cannabinoids like CBG, CBN, and trace amounts of THC.
Because these other Cannabinoids are present in the majority of CBD products sold today, they could be considered a different product than what’s contained in Epidiolex.
While that’s a somewhat weaker argument, we would argue all Hemp-Derived Cannabinoids are clearly dietary supplements, and should have been sold as such for years now.
This lack of oversight & confusion from the FDA regarding Hemp-Derived products has led to false claims, mislabeling, and some unsafe products to be sold around the country.
How You Can Support CBD Become A Dietary Supplement
In order for this bill to pass through the messy situation in Washington there will need to be a grassroots movement that let’s our congress people know how important this bill is. The industry leader when it comes to getting Hemp legislation passed through congress is the U.S. Hemp Roundtable.
This organization played a major role in getting the Farm Bill of 2018 passed, and has worked on a state by state level to ensure the full legalization of Hemp and Hemp Derivatives.
The U.S. Hemp Roundtable has created a very easy to use portal to contact your local legislators. You can find that portal here, and we sincerely encourage everyone reading this article to do so! You simply put in some general information about yourself, and let the Roundtable take care of the rest.
In a time where this country is so divided, Hemp has consistently been an issue that both parties can agree upon. Some examples include Mitch McConnell (R) being a primary reason why the Farm Bill of 2018 was able to be passed, to Oregon State Senator Brad Witt (D) championing a very Hemp friendly bill in the Beaver State.
H.R.-8179 is yet another example where members of both parties can come together on the issue of Hemp. We applaud the effort of both sponsoring members of this bill, and we truly encourage all supporters of Hemp, CBD, or Cannabis in general to contact their senators today so CBD can be marked as a Dietary Supplement!
The content on this site is not intended to be a substitute for professional medical advice, diagnosis or treatment. While research has shown that CBD has the potential to help provide beneficial outcomes for several complaints, it is advisable to seek the advice of a physician or other qualified healthcare provider when you have questions regarding any medical condition and when starting, augmenting or discontinuing any existing health routine.
FDA Disclaimer: Any statements made within this website have not been evaluated by the Food and Drug Administration. No products produced, manufactured, marketed, or distributed are intended to diagnose, treat, cure or prevent any disease. Consult your physician before beginning any supplements or botanical extracts. If pregnant or breast feeding, consult with your physician before use. For use by adults 18+. Keep out of reach of children.